(Q40586640)

21 September 2017

title

Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma (English)

1 reference

21 September 2017

0 references

1 reference

Nagy Habib

1

1 reference

21 September 2017

Hosny Salama

2

1 reference

21 September 2017

Ahmed Abd El Latif Abu Median

3

1 reference

21 September 2017

Ilia Isac Anis

4

1 reference

21 September 2017

Rasha Ahmed Abd Al Aziz

5

1 reference

21 September 2017

Catherine Sarraf

6

1 reference

21 September 2017

Ragai Mitry

7

1 reference

21 September 2017

Roman Havlik

8

1 reference

21 September 2017

Prem Seth

9

1 reference

21 September 2017

Jack Hartwigsen

10

1 reference

21 September 2017

Reva Bhushan

11

1 reference

21 September 2017

Joanna Nicholls

12

1 reference

21 September 2017

Steen Jensen

13

1 reference

21 September 2017

publication date

1 March 2002

1 reference

21 September 2017

1 reference

21 September 2017

volume

9

1 reference

21 September 2017

issue

3

1 reference

21 September 2017

page(s)

254-259

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700431

21 September 2017

exact match

0 references

cites work

Surgical management of hepatocellular carcinoma: resection or transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700431

The molecular genetics of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700431

p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700431

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700431

Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700431

E1B-deleted adenovirus (dl1520) gene therapy for patients with primary and secondary liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700431

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700431

Treatment of hepatocellular carcinoma: too many options?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700431

Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700431

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700431

Surgical resection for small hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700431

7 January 2021

Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700431

7 January 2021

Tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700431

7 January 2021

Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700431

7 January 2021

Electron microscopic assessment of adenovirus-mediated transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700431

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700431

1 reference

Dimensions Publication ID

21 September 2017

1011742175

0 references

1 reference